Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 58

    1.

    Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma.

    Barr PM, Fu P, Lazarus HM, Horvath N, Gerson SL, Koc ON, Bahlis NJ, Snell MR, Dowlati A, Cooper BW.

    Br J Haematol. 2009 Oct;147(1):89-96. Epub 2009 Jun 29.PMID: 19656151 [PubMed - in process]Related articles

    2.

    Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant.

    Barr PM, Lazarus HM, Cooper BW, Schluchter MD, Panneerselvam A, Jacobberger JW, Hsu JW, Janakiraman N, Simic A, Dowlati A, Remick SC.

    Am J Hematol. 2009 Aug;84(8):484-7.PMID: 19536846 [PubMed - indexed for MEDLINE]Related articles

    3.

    Erythema nodosum in association with newly diagnosed hairy cell leukemia and group C streptococcus infection.

    Patel RR, Kirkland EB, Nguyen DH, Cooper BW, Baron ED, Gilliam AC.

    Am J Dermatopathol. 2008 Apr;30(2):160-2.PMID: 18360121 [PubMed - indexed for MEDLINE]Related articles

    4.

    Phthalate induction of CYP3A4 is dependent on glucocorticoid regulation of PXR expression.

    Cooper BW, Cho TM, Thompson PM, Wallace AD.

    Toxicol Sci. 2008 Jun;103(2):268-77. Epub 2008 Mar 10.PMID: 18332045 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.

    van Heeckeren WJ, Fanning LR, Meyerson HJ, Fu P, Lazarus HM, Cooper BW, Tse WW, Kindwall-Keller TL, Jaroscak J, Finney MR, Fox RM, Solchaga L, Forster M, Creger RJ, Laughlin MJ.

    Br J Haematol. 2007 Nov;139(3):464-74.PMID: 17910637 [PubMed - indexed for MEDLINE]Related articles

    6.

    Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation.

    Fu P, van Heeckeren WJ, Wadhwa PD, Bajor DJ, Creger RJ, Xu Z, Cooper BW, Laughlin MJ, Gerson SL, Koç ON, Lazarus HM.

    Contemp Clin Trials. 2008 Mar;29(2):157-64. Epub 2007 Jul 19.PMID: 17707140 [PubMed - indexed for MEDLINE]Related articles

    7.

    Public reporting and pay for performance.

    Cooper BW.

    N Engl J Med. 2007 Apr 26;356(17):1783-4; author reply 1784. No abstract available. PMID: 17465040 [PubMed - indexed for MEDLINE]Related articles

    8.

    Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization.

    Fu P, Bagai RK, Meyerson H, Kane D, Fox RM, Creger RJ, Cooper BW, Gerson SL, Laughlin MJ, Koc ON, Lazarus HM.

    Bone Marrow Transplant. 2006 Aug;38(3):189-96.PMID: 16850032 [PubMed - indexed for MEDLINE]Related articles

    9.

    Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcome.

    Yüksel M, Baron E, Camouse M, Cooper BW, Lazarus HM, Gerson SL, Laughlin MJ, Cooper KD, Gilliam A, Fu P, Stevens S, Koç ON.

    Biol Blood Marrow Transplant. 2006 Jun;12(6):665-71.PMID: 16737940 [PubMed - indexed for MEDLINE]Related articles

    10.

    Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device.

    van Heeckeren WJ, Vollweiler J, Fu P, Cooper BW, Meyerson H, Lazarus HM, Simic A, Laughlin MJ, Gerson SL, Koç ON.

    Br J Haematol. 2006 Jan;132(1):42-55.PMID: 16371019 [PubMed - indexed for MEDLINE]Related articles

    11.

    Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer.

    Cooper BW, Radivoyevitch T, Overmoyer BA, Shenk RR, Pham HT, Samuels JR, Parry MP, Silverman P.

    Breast Cancer Res Treat. 2006 Jun;97(3):311-8. Epub 2005 Dec 13.PMID: 16344915 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.

    Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR Jr, Moseley AB, Bacigalupo A.

    Biol Blood Marrow Transplant. 2005 May;11(5):389-98.PMID: 15846293 [PubMed - indexed for MEDLINE]Related articles

    13.

    High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality.

    Wadhwa PD, Fu P, Koc ON, Cooper BW, Fox RM, Creger RJ, Bajor DL, Bedi T, Laughlin MJ, Payne J, Gerson SL, Lazarus HM.

    Biol Blood Marrow Transplant. 2005 Jan;11(1):13-22.PMID: 15625540 [PubMed - indexed for MEDLINE]Related articles

    14.

    A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia.

    Cooper BW, Veal GJ, Radivoyevitch T, Tilby MJ, Meyerson HJ, Lazarus HM, Koc ON, Creger RJ, Pearson G, Nowell GM, Gosky D, Ingalls ST, Hoppel CL, Gerson SL.

    Clin Cancer Res. 2004 Oct 15;10(20):6830-9.PMID: 15501959 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Smallpox vaccination risks and public policy.

    Cooper BW.

    Ann Intern Med. 2004 Jan 6;140(1):67; author reply 67. No abstract available. PMID: 14706978 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Phase I and correlative study of combination bryostatin 1 and vincristine in relapsed B-cell malignancies.

    Dowlati A, Lazarus HM, Hartman P, Jacobberger JW, Whitacre C, Gerson SL, Ksenich P, Cooper BW, Frisa PS, Gottlieb M, Murgo AJ, Remick SC.

    Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5929-35.PMID: 14676117 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia.

    Cooper BW, Donaher E, Lazarus HM, Green SB, Gosky DM, Rosenthal NS, Berger SJ, Li X, Ingalls ST, Hoppel CL, Gerson SL.

    Leuk Res. 2003 Jan;27(1):35-44.PMID: 12479850 [PubMed - indexed for MEDLINE]Related articles

    18.

    Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: predictors and clinical relevance.

    Pecora AL, Lazarus HM, Jennis AA, Preti RA, Goldberg SL, Rowley SD, Cantwell S, Cooper BW, Copelan EA, Herzig RH, Meagher R, Kennedy MJ, Akard LR, Jansen J, Ross A, Prilutskaya M, Glassco J, Kahn D, Moss TJ.

    Biol Blood Marrow Transplant. 2002;8(10):536-43.PMID: 12434948 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancer.

    Pecora AL, Lazarus HM, Stadtmauer EA, Winter J, Van Vliet A, Berry D, Gray R, Jennis A, Goldberg S, Cooper BW, Preti R.

    Bone Marrow Transplant. 2001 Jun;27(12):1245-53.PMID: 11548842 [PubMed - indexed for MEDLINE]Related articles

    20.

    Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor.

    Schenkein DP, Koc Y, Alcindor T, Stadtmauer EA, Miller KB, Cooper BW, Partridge AH, Lazarus HM.

    Biol Blood Marrow Transplant. 2000;6(4A):448-55.PMID: 10975514 [PubMed - indexed for MEDLINE]Related articles

    21.

    Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.

    Koç ON, Gerson SL, Cooper BW, Laughlin M, Meyerson H, Kutteh L, Fox RM, Szekely EM, Tainer N, Lazarus HM.

    J Clin Oncol. 2000 May;18(9):1824-30.PMID: 10784622 [PubMed - indexed for MEDLINE]Related articles

    22.

    CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome.

    Lazarus HM, Pecora AL, Shea TC, Koç ON, White JM, Gabriel DA, Cooper BW, Gerson SL, Krieger M, Sing AP.

    Bone Marrow Transplant. 2000 Mar;25(5):559-66.PMID: 10713636 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy.

    Koç ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM.

    J Clin Oncol. 2000 Jan;18(2):307-16.PMID: 10637244 [PubMed - indexed for MEDLINE]Related articles

    24.

    Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer.

    Cooper BW, Moss TJ, Ross AA, Ybanez J, Lazarus HM.

    J Clin Oncol. 1998 Nov;16(11):3509-17.PMID: 9817268 [PubMed - indexed for MEDLINE]Related articles

    25.

    Group B streptococcal bacteremia in adults at Hartford Hospital 1991-1996.

    Cooper BW, Morganelli E.

    Conn Med. 1998 Sep;62(9):515-7.PMID: 9785635 [PubMed - indexed for MEDLINE]Related articles

    26.

    Noxious fumes in a medical center: chemical and psychological aspects.

    York E, Hodgson MJ, Cooper BW, McKay CA Jr.

    Conn Med. 1998 Feb;62(2):71-4. Erratum in: Conn Med 1998 Apr;62(4):251. PMID: 9542287 [PubMed - indexed for MEDLINE]Related articles

    27.

    Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.

    Koç ON, Gerson SL, Phillips GL, Cooper BW, Kutteh L, Van Zant G, Reece DE, Fox RM, Schupp JE, Tainer N, Lazarus HM.

    Bone Marrow Transplant. 1998 Feb;21(4):337-43.PMID: 9509966 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Infection control concepts in critical care.

    Dieckhaus KD, Cooper BW.

    Crit Care Clin. 1998 Jan;14(1):55-70. Review.PMID: 9448978 [PubMed - indexed for MEDLINE]Related articles

    29.

    A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.

    Schenkein DP, Roitman D, Miller KB, Morelli J, Stadtmauer E, Pecora AL, Cassileth P, Fernandez H, Cooper BW, Kutteh L, Lazarus HM.

    Biol Blood Marrow Transplant. 1997 Oct;3(4):210-6.PMID: 9360783 [PubMed - indexed for MEDLINE]Related articles

    30.

    Erythroid burst-forming units (BFU-E) predict hematopoietic recovery after peripheral blood progenitor cell transplantation in patients with advanced breast cancer.

    Cooper BW, Mackay W, Gerson SL, Lazarus HM.

    Bone Marrow Transplant. 1997 Jun;19(11):1089-94.PMID: 9193751 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Comparative analysis of breast cancer contamination in mobilized and nonmobilized hematopoietic grafts.

    Ross AA, Layton TJ, Ostrander AB, Passos-Coelho JL, Davis JM, Huelskamp AM, Noga SJ, Davidson NE, Kennedy MJ, Cooper BW, Gerson SL, Lazarus HM, Holland K, Gluck S, Moss TJ, Kaubish A, Vahdat L, Antman K.

    J Hematother. 1996 Oct;5(5):549-52. No abstract available. PMID: 8938527 [PubMed - indexed for MEDLINE]Related articles

    32.

    Cefoperazone/sulbactam versus cefoperazone plus mezlocillin: empiric therapy for febrile, neutropenic bone marrow transplant patients.

    Lazarus HM, Creger RJ, Gucalp R, Fox RM, Ciobanu N, Carlisle PS, Cooper BW, Jacobs MR.

    Int J Antimicrob Agents. 1996 Jul;7(2):85-91.PMID: 18611741 [PubMed - in process]Related articles

    33.

    Severe acute graft-versus-host disease of conjunctivae after allogeneic blood progenitor cell infusion.

    Spiro TP, O'Day DG, Bardenstein D, Cooper BW, Lazarus HM.

    Bone Marrow Transplant. 1996 Jun;17(6):1179-80.PMID: 8807133 [PubMed - indexed for MEDLINE]Related articles

    34.

    Laparoscopic liver biopsy to evaluate hepatic dysfunction in patients with hematologic malignancies: a useful tool to effect changes in management.

    Iqbal M, Creger RJ, Fox RM, Cooper BW, Jacobs G, Stellato TA, Lazarus HM.

    Bone Marrow Transplant. 1996 Apr;17(4):655-62.PMID: 8722371 [PubMed - indexed for MEDLINE]Related articles

    35.

    Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patients.

    Tahsildar HI, Remler BF, Creger RJ, Cooper BW, Snodgrass SM, Tarr RW, Lazarus HM.

    J Neurooncol. 1996 Mar;27(3):241-50.PMID: 8847558 [PubMed - indexed for MEDLINE]Related articles

    36.

    Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditis.

    Nicolau DP, Marangos MN, Nightingale CH, Patel KB, Cooper BW, Quintiliani R Jr, Courvalin P, Quintiliani R.

    Antimicrob Agents Chemother. 1996 Jan;40(1):55-60.PMID: 8787879 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.

    Winter JN, Lazarus HM, Rademaker A, Villa M, Mangan C, Tallman M, Jahnke L, Gordon L, Newman S, Byrd K, Cooper BW, Horvath N, Crum E, Stadtmauer EA, Conklin E, Bauman A, Martin J, Goolsby C, Gerson SL, Bender J, O'Gorman M.

    J Clin Oncol. 1996 Jan;14(1):277-86.PMID: 8558209 [PubMed - indexed for MEDLINE]Related articles

    38.

    Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancer.

    Lazarus HM, Winton EF, Williams SF, Grinblatt D, Campion M, Cooper BW, Gunn H, Manfreda S, Isaacs RE.

    Bone Marrow Transplant. 1995 Jun;15(6):935-42.PMID: 7581094 [PubMed - indexed for MEDLINE]Related articles

    39.

    Acute cholecystitis after autologous bone marrow transplantation for acute myeloid leukemia.

    Kuttah L, Weber F, Creger RJ, Fox RM, Cooper BW, Jacobs G, Lazarus HM.

    Ann Oncol. 1995 Mar;6(3):302-4.PMID: 7612498 [PubMed - indexed for MEDLINE]Related articles

    40.

    Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.

    Fields KK, Elfenbein GJ, Lazarus HM, Cooper BW, Perkins JB, Creger RJ, Ballester OF, Hiemenz JH, Janssen WE, Zorsky PE.

    J Clin Oncol. 1995 Feb;13(2):323-32.PMID: 7844593 [PubMed - indexed for MEDLINE]Related articles

    41.

    Immunization with high-dose intradermal recombinant hepatitis B vaccine in healthcare workers who failed to respond to intramuscular vaccination.

    Levitz RE, Cooper BW, Regan HC.

    Infect Control Hosp Epidemiol. 1995 Feb;16(2):88-91.PMID: 7759824 [PubMed - indexed for MEDLINE]Related articles

    42.

    Hepatic dysfunction in patients with carcinoma who are severely thrombocytopenic and immunosuppressed.

    Lazarus HM, Creger RJ, Fox RM, Cooper BW, Jacobs G, Stellato TA.

    J Am Coll Surg. 1994 Oct;179(4):433-9.PMID: 7921393 [PubMed - indexed for MEDLINE]Related articles

    43.

    Sequential administration of recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a phase I/II multicenter study.

    Fay JW, Lazarus H, Herzig R, Saez R, Stevens DA, Collins RH Jr, Piñeiro LA, Cooper BW, DiCesare J, Campion M, et al.

    Blood. 1994 Oct 1;84(7):2151-7.PMID: 7919329 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    An inflammatory eruption associated with recombinant human IL-6.

    Fleming TE, Mirando WS, Soohoo LF, Cooper BW, Zaim MT, Lazarus HM, Elmets CA.

    Br J Dermatol. 1994 Apr;130(4):534-6.PMID: 8186125 [PubMed - indexed for MEDLINE]Related articles

    45.

    Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques.

    Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D, et al.

    Blood. 1993 Nov 1;82(9):2605-10.PMID: 8219214 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies.

    Crilley P, Lazarus H, Topolsky D, Ciobanu N, Creger RJ, Fox RM, Bulova SI, Shina DC, Gucalp R, Cooper BW, et al.

    Semin Oncol. 1993 Aug;20(4 Suppl 4):50-4; quiz 55.PMID: 8342076 [PubMed - indexed for MEDLINE]Related articles

    47.

    Renal dysfunction during high-dose cisplatin therapy and autologous hematopoietic stem cell transplantation: effect of aminoglycoside therapy.

    Cooper BW, Creger RJ, Soegiarso W, Mackay WL, Lazarus HM.

    Am J Med. 1993 May;94(5):497-504.PMID: 8098904 [PubMed - indexed for MEDLINE]Related articles

    48.

    Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis.

    Nicolau DP, Freeman CD, Nightingale CH, Quintiliani R, Coe CJ, Maderazo EG, Cooper BW.

    Infect Immun. 1993 Apr;61(4):1593-5.PMID: 8454370 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model.

    Sullivan MC, Cooper BW, Nightingale CH, Quintiliani R, Lawlor MT.

    Antimicrob Agents Chemother. 1993 Feb;37(2):234-9.PMID: 8452353 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma.

    Lazarus HM, Crilley P, Ciobanu N, Creger RJ, Fox RM, Shina DC, Bulova SI, Gucalp R, Cooper BW, Topolsky D, et al.

    J Clin Oncol. 1992 Nov;10(11):1682-9.PMID: 1403051 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...